| [1] PubMed ID: | 33976732 |
| Disease Name: | Stomach Neoplasms |
| Tissue: | Plasma |
| Dysfunction Pattern: | Down-Regulation |
| Validated Method: | RT-PCR//High-throughput sequencing |
| Description: | N/A |
| Comparision: | Cancer VS Normal |
| Mechanism: | tRF-19-3L7L73JD inhibited cell proliferation and migration, induced apoptosis, and arrested cells at G0/G1 phases, suggesting it may suppress the development of gastric cancer. |
| [2] PubMed ID: | 36036848 |
| Disease Name: | Stomach Neoplasms |
| Tissue: | Plasma |
| Dysfunction Pattern: | Down-Regulation |
| Validated Method: | High-throughput sequencing |
| Description: | N/A |
| Comparision: | Cancer VS Normal |
| Mechanism: | N/A |
| [3] PubMed ID: | 36464183 |
| Disease Name: | Stomach Neoplasms |
| Tissue: | Plasma |
| Dysfunction Pattern: | Down-Regulation |
| Validated Method: | RT-PCR |
| Description: | tRF-19-3L7L73JD showed lower expression in the tested gastric cancer patients. |
| Comparision: | Cancer VS Normal |
| Mechanism: | tRF-19-3L7L73JD inhibited cell proliferation and migration, induced apoptosis, and arrested cells at G0/G1 phases. |
|